The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: A potential therapeutic opportunity for atherosclerotic thrombosis-Reference-Cited by-同舟云学术

The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: A potential therapeutic opportunity for atherosclerotic thrombosis

Published:2014-04 Issue:4 Volume:133 Page:657-666
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Jiang Pengfei,Xue Dong,Zhang Yingjia,Ye Longwu,Liu Yuan,Makale Milan,Kesari Santosh,Edgington Thomas S.,Liu Cheng

Funder

US National Cancer Institute

US Department of Defense

Publisher

Elsevier BV

Subject

Hematology

Reference45 articles.

1. Atherosclerosis;Lusis;Nature,2000

2. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences;Viles-Gonzalez;Eur Heart J,2004

3. The proteomic approach in the development of prognostic biomarkers in atherothrombosis;Lorenzo;Recent Pat Cardiovasc Drug Discov,2009

4. P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice;Furlan-Freguia;J Clin Invest,2011

5. Antiplatelet therapy and vascular disease: an update;Buch;Ther Adv Cardiovasc Dis,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment and Clinical Features in Patients with Lung Cancer Complicated by Trousseau’s Syndrome;Advances in Clinical Medicine;2024

2. The Technical Feasibility of Digital Spatial Profiling in Immune/Inflammation Study of Thrombosis;Journal of Inflammation Research;2023-06

3. Anti-CXCR2 antibody-coated nanoparticles with an erythrocyte-platelet hybrid membrane layer for atherosclerosis therapy;Journal of Controlled Release;2023-04

4. Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group;Clinical and Translational Oncology;2022-06-06

5. Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors;Frontiers in Pharmacology;2021-11-08